Labetalol Hydrochloride 71209-0085
Product NDC
71209-0085- Manufacturer
- Cadila Pharmaceuticals Limited
- Dosage Form
- Tablet, Film Coated
- Route
- Oral
- Product Type
- Human Prescription Drug
- Marketing Start
- March 5, 2018
- Listing Expires
- December 31, 2026
- Application
- ANDA211325
Need to source Labetalol Hydrochloride? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Labetalol Hydrochloride | 300 mg/1 |
Drug Class
Adrenergic beta-Antagonists [MoA]beta-Adrenergic Blocker [EPC]
Packaging Options(4)
60 TABLET, FILM COATED in 1 BOTTLE (71209-085-03)
100 TABLET, FILM COATED in 1 BOTTLE (71209-085-05)
500 TABLET, FILM COATED in 1 BOTTLE (71209-085-10)
1000 TABLET, FILM COATED in 1 BOTTLE (71209-085-11)